Press Release

gaudium® IVF Delivering Motherhood Dreams July 16, 2026 National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Dalal Street, Fort, Kurla Complex, Bandra (E), Mumbai — Mumbai — 400001 400051 Scrip Code — 544709 Symbol - GAUDIUMIVF ISIN: INEOP8B01020 ISIN: INEOP8B01020 Dear Sir/Madam, Subject: Press Release Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in terms of other applicable laws, if any, please find enclosed Press Release titled “India's First Listed IVF Company, Gaudium IVF, Unveils Al Powered Signature Labs, Kicking Off Planned 19 Centre Expansion.” The above is being made available on the Company’s website i.e. www.gaudiumivfcentre.com. This is for your information, records and appropriate dissemination. Thanking You, Yours faithfully, For and on behalf of Gaudium IVF and Women Health Limited (Formerly Known as Gaudium IVF and Women Health Private Limited) Naveen Kumar Company Secretary and Compliance Officer Membership No: A69788 Encl: a/a Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com EI% {0] India's First Listed IVF Company, Gaudium IVF, Unveils AI Powered Signature Labs, Kicking Off Planned 19 Centre Expansion The new centre combines AI-assisted embryology, globally benchmarked Signature Lab standards, 17 years of fer(cid:415)lity exper(cid:415)se and proven experience in complex IVF cases New Delhi, 16 July 2026: Gaudium IVF and Women Health Limited, India's first publicly listed IVF chain, today kicked off its first milestone in the Company's planned 19-centre expansion, as outlined in the growth roadmap shared with investors during its IPO. The launch reinforces the Company's commitment to making high quality, technology driven fer(cid:415)lity care more accessible to aspiring parents through a standardised clinical and laboratory model that combines AI powered innova(cid:415)on with the highest standards of clinical excellence, pa(cid:415)ent safety and ethical care. Strategically located in South Delhi, the new centre offers comprehensive fer(cid:415)lity care under one roof, combining experienced fer(cid:415)lity specialists, advanced reproduc(cid:415)ve medicine and Gaudium IVF's standardised clinical protocols. At the heart of the new centre is the Gaudium Signature Lab, the Company's proprietary laboratory framework that integrates advanced embryology, AI-powered technologies and interna(cid:415)onally benchmarked quality standards to create an op(cid:415)mal environment for embryo development. As Gaudium IVF expands its network, the Signature Lab model will be replicated across every new centre, ensuring pa(cid:415)ents experience the same high standards of precision, safety and clinical excellence, irrespec(cid:415)ve of loca(cid:415)on. The centre also brings together Gaudium IVF's AI-powered embryology ecosystem, including SiD (Sperm Iden(cid:415)fica(cid:415)on Device) for advanced sperm assessment and ERICA (Embryo Ranking Intelligent Classifica(cid:415)on Assistant) for embryo evalua(cid:415)on. By complemen(cid:415)ng the exper(cid:415)se of embryologists with data-driven insights, these technologies enhance precision, consistency and confidence throughout the IVF journey. Built on a 17-year legacy of innova(cid:415)on and pa(cid:415)ent-centric care, Gaudium IVF has established itself as one of India's trusted fer(cid:415)lity care providers. Its commitment to laboratory excellence has been recognised interna(cid:415)onally with the European Quality Award from ESQR, Spain, reinforcing the high standards that underpin the Company's clinical outcomes, including in complex infer(cid:415)lity and recurrent IVF failure cases. Commen(cid:415)ng on the launch, Dr. Manika Khanna, Chairperson and Managing Director, Gaudium IVF, said: "Fer(cid:415)lity care is one of the most specialised fields of medicine, where science, clinical exper(cid:415)se and ethical prac(cid:415)ces come together to help couples realise their dream of parenthood. At Gaudium IVF, we believe every pa(cid:415)ent deserves care that is not only clinically advanced but also transparent, compassionate and centred around their individual needs. The launch of our South Extension centre reflects our commitment to making world-class fer(cid:415)lity care more accessible without compromising on the standards that have guided us for the past 17 years. As we expand our network, our focus remains on building centres that combine scien(cid:415)fic excellence, AI-powered innova(cid:415)on and globally benchmarked laboratory standards with a pa(cid:415)ent-first approach. The Gaudium Signature Lab reflects this philosophy by bringing together qualified embryologists, technologically advanced laboratory, ethical prac(cid:415)ces and evidence-based care to support informed clinical decisions and provide pa(cid:415)ents with the highest standards of fer(cid:415)lity care. These principles will con(cid:415)nue to guide every step of our growth journey." The launch comes at a (cid:415)me when demand for specialised fer(cid:415)lity care con(cid:415)nues to grow across India, driven by delayed parenthood, changing lifestyles and increasing awareness of assisted reproduc(cid:415)ve technologies. Through its planned network expansion, Gaudium IVF aims to replicate its Signature Lab model across new centres, combining advanced reproduc(cid:415)ve medicine, AI-powered embryology and standardised clinical protocols to deliver consistent, high-quality fer(cid:415)lity care at scale and reinforce its leadership in India's rapidly evolving fer(cid:415)lity care sector. About Gaudium IVF and Women Health Limited Founded in 2009, Gaudium IVF and Women Health Limited is a leading fertility care provider with a PAN India presence and a growing global reach. Recently becoming India’s first publicly listed IVF chain, the organisation has consistently pushed the boundaries of reproductive healthcare innovation in the country. With the introduction of AI-led embryology, Gaudium IVF continues to redefine the future of fertility treatment, reinforcing its position as an industry pioneer. Under the leadership of Manika Khanna, the organisation is known for its patient-centric approach, advanced clinical excellence, and continuous focus on innovation in reproductive medicine. For more information, please contact Mr. Rakesh Kumar Sharma (CFO) cfo@gaudiumivfcentre.com Investor Relations: Rushabh Shah/ Anand Venugopal rushabh.shah@adfactorspr.com / anand.venugopal@adfactorspr.com PR & Media Relations: Apoorva Sharma apoorva.sharma@adfactorspr.com